Kazia Therapeutics Retorno sobre activos
¿Qué es el Retorno sobre activos de Kazia Therapeutics?
El Retorno sobre activos de Kazia Therapeutics Limited es -33.41%
¿Cuál es la definición de Retorno sobre activos?
El rendimiento de los activos indica cuál rentables son los activos de una empresa para generar ingresos. Se calcula dividiendo la utilidad neta por el promedio de los activos totales.
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Retorno sobre activos de compañías en Sector Health Care en ASX en comparadas con Kazia Therapeutics
¿Qué hace Kazia Therapeutics?
Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is GDC-0084, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. The company is also developing Cantrixil, which is being developed for the treatment of ovarian cancer and is in hospitals across Australia and the United States under an Investigational New Drug application. Kazia Therapeutics Limited has collaboration agreements St Jude Childrens Hospital; Dana-Farber Cancer Institute; Alliance for Clinical Trials in Oncology; Memorial Sloan Kettering Cancer Centre; and University of Newcastle. The company was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was founded in 1994 and is based in Sydney, Australia.
Empresas con retorno sobre activos similar a Kazia Therapeutics
- Epigenomics AG tiene Retorno sobre activos de -33.48%
- Kogi Iron tiene Retorno sobre activos de -33.44%
- ReNeuron plc tiene Retorno sobre activos de -33.44%
- Pivotal Systems tiene Retorno sobre activos de -33.43%
- East Asia Minerals tiene Retorno sobre activos de -33.43%
- Jessy Ventures tiene Retorno sobre activos de -33.41%
- Kazia Therapeutics tiene Retorno sobre activos de -33.41%
- Moderna Dl ,0001 tiene Retorno sobre activos de -33.39%
- Moderna Inc tiene Retorno sobre activos de -33.39%
- Equus Mining tiene Retorno sobre activos de -33.39%
- Emergent Biosolutions Inc tiene Retorno sobre activos de -33.38%
- Litian Pictures tiene Retorno sobre activos de -33.34%
- Invion tiene Retorno sobre activos de -33.34%